Поисковый запрос: (<.>S=КАРБАПЕНЕМНЫЕ АНТИБИОТИКИ<.>) |
Общее количество найденных документов : 47
Показаны документы с 1 по 20
|
|
1.
| Carbapenem compounds and use
|
2.
| Kim Choung U. Carbapenem antibiotics
|
3.
| Carbepenem derivatives
|
4.
| Carbepenem derivatives
|
5.
| Carbepenem derivatives
|
6.
| Jasys Vitautas J. Antibacterial 2-carbapenem derivatives
|
7.
| Parsons William H. Method of treating bacterial infection with phosphorus containing DHP enzyme inhibitors
|
8.
| Heck James V. Quaternary heteroarylalkylthio carbapenems naving an acid moiety substittuent
|
9.
| Salzmann Thomas N. Enantioselective process for producing 1-betamethylcarbapenem antibiotic intermediates
|
10.
| Antibacterially effective methods and compositions based upon (1R,5S,6S)-2[(6,7-dihydro-5Н-pyrazolo[1,2-А][1,2,4]triazolium-6-yl)thio-6-[R1-hydroxyethyl]-1-methyl-carbapenem-3-caroxylate and salts therefore
|
11.
| In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 12.-С.4388-4399
|
12.
| Cryptic carbapenem antibiotic production genes are widespread in Erwinia carotovora: Facile trans activation by the carR transcriptional regulator // Microbiology, 1998. Vol. 144, N 6.-С.1495-1508
|
13.
| Yasuda Carbapenems // Sankyo kenkyujo nenpo, 1996. Vol. 48.-С.131-132
|
14.
| Yasuda Carbapenems // Sankyo kenkyujo nenpo, 1996. Vol. 48.-С.131-132
|
15.
| Iaconis Joseph P. Potential factors influencing carbapenem activity against Bacteroides fragilis group isolates // Clin. Infec. Diseases, 1995. Vol. 20, Suppl. n 2.-С.361-363
|
16.
| Synthesis and antibacterial activity of new 1'бета'-methyl carbapenem having a thiazolo[3,2-'альфа']benzimidazole moiety // Arch. Pharm., 1995. Vol. 328, N 3.-С.289-291
|
17.
| Synthesis and antibacterial activity of new 1'бета'-methyl carbapenem having a thiazolo[3,2-'альфа']benzimidazole moiety // Arch. Pharm., 1995. Vol. 328, N 3.-С.289-291
|
18.
| Carbapenems - efficacy and safety profiles: Focus on meropenem // Scand. J. Infec. Diseases. Suppl., 1995, N 96.-С.1-48
|
19.
| Carbapenems - efficacy and safety profiles: Focus on meropenem // Scand. J. Infec. Diseases. Suppl., 1995, N 96.-С.1-48
|
20.
| Iaconis Joseph P. Potential factors influencing carbapenem activity against Bacteroides fragilis group isolates // Clin. Infec. Diseases, 1995. Vol. 20, Suppl. n 2.-С.361-363
|
&uf('+1W2226#',v2226), ?>
|
|